PDA

View Full Version : Denosumab may benefit postmenopausal patients with hormone receptor-negative breast t


News
03-08-2023, 03:07 PM
The drug denosumab is currently used to treat osteoporosis and bone metastases. For more than a decade, its potential therapeutic benefit in the treatment of breast cancer has also been studied.

More... (https://www.news-medical.net/news/20230307/Denosumab-may-benefit-postmenopausal-patients-with-hormone-receptor-negative-breast-tumors-and-RANK-protein-expression.aspx)